The key objective was to determine appropriate analytical targets by analyzing human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to verify the final results in genuine urine specimens and to determine AB-FUBINACA's metabolic stability in human liver microsomes and in comparison hepatocyte and urine effects with in silico https://georgec050pft4.bcbloggers.com/profile